Catherine M.  Szyman net worth and biography

Catherine Szyman Biography and Net Worth

Catherine "Katie" Szyman is the corporate vice president, critical care at Edwards Lifesciences Corp., a role she has held since 2015. 

Prior to Edwards, Szyman spent over 20 years at Medtronic, where she held the role of SVP and president of its global diabetes business from 2009 to 2014, overseeing research, development, sales, marketing and operations for its insulin infusion pumps and continuous glucose monitoring systems.

Additionally, Szyman held multiple leadership positions at Medtronic, including SVP of corporate strategy and business development, general manager of endovascular innovations and VP of finance for the cardiovascular business. She currently sits on the boards of Endotronix, Octane OC, Outset Medical, the American Heart Association of Orange County, Opus School of Business and Inari Medical, and she previously served on the boards of Inspire Medical Systems, Tornier, and the California Healthcare Institute.

Szyman earned her bachelor’s degree from the University of St. Thomas in St. Paul, Minnesota, and she holds an M.B.A. from Harvard Business School.

What is Catherine M. Szyman's net worth?

The estimated net worth of Catherine M. Szyman is at least $2.40 million as of October 10th, 2023. Ms. Szyman owns 34,814 shares of Edwards Lifesciences stock worth more than $2,396,944 as of December 6th. This net worth approximation does not reflect any other assets that Ms. Szyman may own. Learn More about Catherine M. Szyman's net worth.

How do I contact Catherine M. Szyman?

The corporate mailing address for Ms. Szyman and other Edwards Lifesciences executives is ONE EDWARDS WAY, IRVINE CA, 92614. Edwards Lifesciences can also be reached via phone at (949) 250-2500 and via email at [email protected]. Learn More on Catherine M. Szyman's contact information.

Has Catherine M. Szyman been buying or selling shares of Edwards Lifesciences?

Within the last three months, Catherine M. Szyman has sold $363,400.00 in shares of Edwards Lifesciences stock. Most recently, Catherine M. Szyman sold 5,000 shares of the business's stock in a transaction on Tuesday, October 10th. The shares were sold at an average price of $72.68, for a transaction totalling $363,400.00. Following the completion of the sale, the vice president now directly owns 34,814 shares of the company's stock, valued at $2,530,281.52. Learn More on Catherine M. Szyman's trading history.

Who are Edwards Lifesciences' active insiders?

Edwards Lifesciences' insider roster includes Donald Bobo, Jr (VP), Daveen Chopra (VP), Kieran Gallahue (Director), Leslie Heisz (Director), Jean-Luc Lemercier (VP), Martha Marsh (Director), Michael Mussallem (CEO), Robert Sellers (VP), Catherine Szyman (VP), Scott Ullem (CFO), Nicholas Valeriani (Director), Huimin Wang (VP), Larry Wood (VP), and Bernard Zovighian (VP). Learn More on Edwards Lifesciences' active insiders.

Are insiders buying or selling shares of Edwards Lifesciences?

In the last year, insiders at the medical research company sold shares 52 times. They sold a total of 622,961 shares worth more than $49,868,390.96. The most recent insider tranaction occured on November, 13th when insider Larry L Wood sold 8,660 shares worth more than $565,498.00. Insiders at Edwards Lifesciences own 1.3% of the company. Learn More about insider trades at Edwards Lifesciences.

Information on this page was last updated on 11/13/2023.

Catherine M. Szyman Insider Trading History at Edwards Lifesciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/10/2023Sell5,000$72.68$363,400.0034,814View SEC Filing Icon  
9/8/2023Sell5,000$76.00$380,000.0034,814View SEC Filing Icon  
8/9/2023Sell5,000$78.64$393,200.0034,814View SEC Filing Icon  
7/10/2023Sell5,000$90.52$452,600.0034,814View SEC Filing Icon  
6/13/2023Sell5,000$85.81$429,050.0035,056View SEC Filing Icon  
5/4/2022Sell23,400$104.86$2,453,724.0030,851View SEC Filing Icon  
4/11/2022Sell20,000$122.04$2,440,800.0027,569View SEC Filing Icon  
3/14/2022Sell20,000$104.65$2,093,000.00View SEC Filing Icon  
2/18/2022Sell20,000$106.31$2,126,200.00View SEC Filing Icon  
1/14/2022Sell10,000$119.53$1,195,300.00View SEC Filing Icon  
12/17/2021Sell10,000$121.24$1,212,400.00View SEC Filing Icon  
11/18/2021Sell10,000$117.79$1,177,900.00View SEC Filing Icon  
10/18/2021Sell9,741$110.41$1,075,503.81View SEC Filing Icon  
8/2/2021Sell15,000$113.53$1,702,950.0042,759View SEC Filing Icon  
5/28/2021Sell2,061$95.29$196,392.6927,705View SEC Filing Icon  
5/25/2021Sell4,665$96.09$448,259.8529,766View SEC Filing Icon  
4/22/2021Sell3,389$94.40$319,921.6030,355View SEC Filing Icon  
2/16/2021Sell3,389$88.20$298,909.8030,135View SEC Filing Icon  
10/29/2020Sell20,355$73.24$1,490,800.2047,101View SEC Filing Icon  
8/13/2020Sell2,249$78.24$175,961.7626,746View SEC Filing Icon  
7/14/2020Sell2,249$67.66$152,167.3428,995View SEC Filing Icon  
6/11/2020Sell2,249$68.06$153,066.9434,564View SEC Filing Icon  
5/13/2020Sell750$216.93$162,697.5018,318View SEC Filing Icon  
4/16/2020Sell1,116$216.91$242,071.5614,755View SEC Filing Icon  
3/23/2020Sell1,116$162.95$181,852.2015,773View SEC Filing Icon  
2/18/2020Sell2,500$228.57$571,425.0019,389View SEC Filing Icon  
12/16/2019Sell2,500$234.27$585,675.0019,605View SEC Filing Icon  
11/15/2019Sell2,500$242.14$605,350.0019,605View SEC Filing Icon  
10/25/2019Sell2,500$227.19$567,975.0019,605View SEC Filing Icon  
9/19/2019Sell2,500$216.71$541,775.0020,138View SEC Filing Icon  
8/15/2019Sell372$214.53$79,805.1618,010View SEC Filing Icon  
7/15/2019Sell1,152$191.70$220,838.4019,162View SEC Filing Icon  
6/14/2019Sell1,474$184.55$272,026.7020,250View SEC Filing Icon  
5/15/2019Sell1,474$177.92$262,254.0821,396View SEC Filing Icon  
4/15/2019Sell1,474$192.00$283,008.0021,132View SEC Filing Icon  
3/15/2019Sell1,146$179.10$205,248.6022,229View SEC Filing Icon  
2/21/2019Sell1,474$176.34$259,925.1615,905View SEC Filing Icon  
1/15/2019Sell700$155.00$108,500.0024,482View SEC Filing Icon  
10/15/2018Sell700$142.64$99,848.0027,772View SEC Filing Icon  
5/24/2018Sell9,815$139.39$1,368,112.8520,012View SEC Filing Icon  
7/31/2017Sell4,681$115.78$541,966.18View SEC Filing Icon  
11/30/2016Buy12,870$83.43$1,073,744.10View SEC Filing Icon  
See Full Table

Catherine M. Szyman Buying and Selling Activity at Edwards Lifesciences

This chart shows Catherine M Szyman's buying and selling at Edwards Lifesciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Edwards Lifesciences Company Overview

Edwards Lifesciences logo
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Read More

Today's Range

Now: $69.62
Low: $68.34
High: $70.18

50 Day Range

MA: $68.00
Low: $61.72
High: $73.70

2 Week Range

Now: $69.62
Low: $60.57
High: $94.87


1,371,821 shs

Average Volume

3,462,218 shs

Market Capitalization

$42.22 billion

P/E Ratio


Dividend Yield